Indication: Vildagliptin is an oral DPP-4 inhibitor approved for the treatment of type 2 diabetes. By inhibiting Dpp-4 and increasing GLP-1 levels, It results in higher insulin and lower glucose levels, particularly after eating.
PACKING: 10 X 1 X 15
PTR: 0.00
SHIPPER: 1
MRP: 0.00
% GAIN: 0.00
Similar Product: JALRA
Elder Labs Ltd. Is a Pharmaceutical company engaged in Research & Development, Manufacturing, Marketing and sale of finished formulations across the world.
Copyright © 2022 All rights reserved.
